Docoh
Loading...

PTGX Protagonist Therapeutics

GRANT
Utility
α4α7 peptide monomer and dimer antagonists
7 Sep 21
The invention relates to peptide dimer compounds and peptide monomer compounds that potently inhibit binding of α4β7 to the mucosal addressin cell adhesion molecule (MAdCAM) in vivo, possess high selectivity against α4β1 binding, and have high stability under gastrointestinal conditions.
Ashok Bhandari, Dinesh V. Patel, Genet Zemede, Larry C. Mattheakis, David Liu
Filed: 4 Feb 20
APP
Utility
Peptide Inhibitors of INTERLEUKIN-23 Receptor and Their Use to Treat Inflammatory Diseases
26 Aug 21
The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases.
Chengzao Sun, Brian Troy Frederick, Sandeep Somani, Gregory Thomas Bourne, Raymond Patch, Ashok Bhandari, Raffaele Ingenito, Roberto Costante, Danila Branca, Elisabetta Bianchi
Filed: 14 Jan 21
GRANT
Utility
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
22 Jun 21
The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases.
Ashok Bhandari, Brian Troy Frederick, David Clifford Sullivan
Filed: 24 Aug 20
APP
Utility
Analogues of Hepcidin Mimetics with Improved In Vivo Half Lifes
20 May 21
The present invention provides hepcidin analogues with improved in vivo half lives, and related pharmaceutical compositions and methods of use thereof.
Gregory Thomas Bourne, Mark Leslie Smythe, Brian Troy Frederick, Ashok Bhandari
Filed: 1 Oct 20
GRANT
Utility
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
9 Mar 21
Peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel disease, are disclosed.
Ashok Bhandari, Gregory Thomas Bourne, Xiaoli Cheng, Brian Troy Frederick, Jie Zhang, Dinesh V. Patel, David Liu
Filed: 12 Dec 18
APP
Utility
Conjugated Hepcidin Mimetics
4 Mar 21
The present invention provides hepcidin analogues, and related pharmaceutical compositions and use thereof in treating polycythemia vera.
David Y. Liu, Gregory Thomas Bourne, Roopa Taranath, Suneel Kumar Gupta, Nishit Bachulal Modi
Filed: 3 Sep 20
APP
Utility
Peptide Inhibitors of INTERLEUKIN-23 Receptor and Their Use to Treat Inflammatory Diseases
14 Jan 21
The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases.
Ashok Bhandari, Brian Troy Frederick, David Clifford Sullivan
Filed: 24 Aug 20
APP
Utility
NOVEL a4B7 PEPTIDE MONOMER AND DIMER ANTAGONISTS
30 Sep 20
The invention relates to peptide dimer compounds and peptide monomer compounds that potently inhibit binding of α4β7 to the mucosal addressin cell adhesion molecule (MAdCAM) in vivo, possess high selectivity against α4β1 binding, and have high stability under gastrointestinal conditions.
Ashok BHANDARI, Dinesh V. PATEL, Genet Zemede, Larry C. Mattheakis, David Liu
Filed: 3 Feb 20
GRANT
Utility
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
28 Sep 20
Peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases, are described.
Ashok Bhandari, Gregory Bourne, Xiaoli Cheng, Brian Troy Frederick, Jie Zhang, Dinesh V. Patel, David Liu
Filed: 14 Jul 16
GRANT
Utility
Opioid agonist peptides and uses thereof
3 Aug 20
The invention is directed to opioid agonist peptides and their use.
Sampath Kumar Anandan, Jie Zhang, Ashok Bhandari, Gregory Thomas Bourne, Brian Troy Frederick, Larry C. Mattheakis, David Liu, Mukund M. Mehrotra
Filed: 5 Mar 19
APP
Utility
NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS
29 Jul 20
The invention relates to thioether monomer and dimer peptide molecules which inhibit binding of α4β7 to the mucosal addressing cell adhesion molecule (MAdCAM) in vivo.
Ashok Bhandari, Dinesh V. Patel, Genet Zemede, Brian Troy Frederick, Larry C. Mattheakis, David Liu
Filed: 27 Jan 20
APP
Utility
Peptide Inhibitors of INTERLEUKIN-23 Receptor and Their Use to Treat Inflammatory Diseases
1 Jul 20
The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases.
Ashok BHANDARI, Gregory Thomas BOURNE
Filed: 17 Jan 18
GRANT
Utility
α4β7 thioether peptide dimer antagonists
20 Apr 20
The invention relates to thioether monomer and dimer peptide molecules which inhibit binding of α4β7 to the mucosal addressing cell adhesion molecule (MAdCAM) in vivo.
Ashok Bhandari, Dinesh V. Patel, Genet Zemede, Brian Troy Frederick, Larry C. Mattheakis, David Liu
Filed: 18 Jul 18
APP
Utility
Methods for Determining and Monitoring Gastrointestinal Inflammation
26 Feb 20
The present invention provides methods for determining levels of biomarkers of inflammation in samples from human patients, e.g., patients undergoing treatment with a peptide inhibitor of interleukin-23 receptor.
Xiaoli CHENG, Roopa TARANATH
Filed: 8 Nov 17
APP
Utility
Peptide Inhibitors of INTERLEUKIN-23 Receptor and Their Use to Treat Inflammatory Diseases
5 Feb 20
The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases.
Ashok Bhandari, Brian Troy Frederick, David Clifford Sullivan
Filed: 11 Jul 19
APP
Utility
NOVEL a4B7 PEPTIDE ANTAGONISTS
15 Jan 20
The invention relates to disulfide-rich peptide molecules which inhibit binding of α4β7 to the mucosal addressin cell adhesion molecule (MAdCAM) in vivo, and show high selectivity against α4β1 binding.
Ashok Bhandari, Dinesh V. Patel, Larry C. Mattheakis
Filed: 21 Feb 19
APP
Utility
Hepcidin and Mini-hepcidin Analogues and Uses Therof
15 Jan 20
The present invention provides novel hepcidin analogues, and related methods of using these hepcidin analogues to treat or prevent a variety of diseases and disorders, including iron overload diseases such as hereditary hemochromatosis, iron-loading anemias, and other conditions and disorders described herein.
Gregory Thomas BOURNE, Mark Leslie SMYTHE, Brian Troy FREDERICK, Simone VINK
Filed: 11 Jun 19
GRANT
Utility
Hepcidin analogues and uses thereof
9 Dec 19
The present invention relates, inter alia, to certain hepcidin peptide analogues, including peptides and dimers thereof, and to the use of the peptides and peptide dimers in the treatment and/or prevention of a variety of diseases, conditions or disorders, including treatment and/or prevention of iron overload diseases, which include hereditary hemochromatosis and iron-loading anemias, and other conditions and disorders described herein.
Mark Leslie Smythe, Gregory Thomas Bourne, Simone Vink, Brian Troy Frederick, Praveen Madala, Anne Pernille Tofteng Shelton, Jacob Ulrik Fog
Filed: 27 Feb 19
APP
Utility
Oral Peptide Inhibitors of INTERLEUKIN-23 Receptor and Their Use to Treat Inflammatory Bowel Diseases
6 Nov 19
Peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel disease, are disclosed.
Ashok Bhandari, Gregory Thomas BOURNE, Xiaoli Cheng, Brian Troy Frederick, Jie Zhang, Dinesh V. Patel, David Liu
Filed: 11 Dec 18
GRANT
Utility
Hepcidin analogues and uses thereof
14 Oct 19
The present invention relates, inter alia, to certain hepcidin peptide analogs, including peptides and dimers thereof, and to the use of the peptides and peptide dimers in the treatment and/or prevention of a variety of diseases, conditions or disorders, including treatment and/or prevention of iron overload diseases, which include hereditary hemochromatosis and iron-loading anemias, and other conditions and disorders described herein.
Mark Leslie Smythe, Gregory Thomas Bourne, Simone Vink, Brian Troy Frederick, Praveen Madala, Anne Pernille Tofteng Shelton, Jacob Ulrik Fog
Filed: 16 Jul 18
Patents are sorted by USPTO publication date, most recent first